GlassScriptPhysician profile
Joseph Allencherril
NPI 1053765016
$8,267.44
in general payments reported to CMS, 2019-2025
27 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,365 · 2020: $933 · 2021: $2,471 · 2022: $2,598 · 2023: $665 · 2024: $117 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675 · Education: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $674.55 |
| Education | $226.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,179.50 | 2021-2024 | Cardiomems, Perclose Proglide |
| Abiomed | $918.52 | 2019-2022 | |
| Medtronic, INC. | $676.14 | 2021-2024 | Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Actelion Pharmaceuticals US, INC. | $658.00 | 2019-2023 | Uptravi, Opsumit |
| Astellas Pharma US INC | $654.30 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $625.05 | 2020-2025 | Lifevest |
| Boston Scientific Corporation | $451.47 | 2021-2025 | Watchman Access System, Farapulse, Wolverine Coronary Cutting Balloon |
| Pfizer INC. | $371.25 | 2019-2023 | |
| Amgen INC. | $313.04 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $311.45 | 2022-2023 | Optimizer |
| Medtronic Vascular, INC. | $226.93 | 2019 | |
| W. L. Gore & Associates, INC. | $216.42 | 2019-2023 | Gore Cardioform Septal Occluder |
| E.R. Squibb & Sons, L.L.C. | $213.55 | 2019-2022 | |
| Inari Medical, INC. | $207.60 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $179.85 | 2019-2023 | Farxiga |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $178.59 | 2022 | |
| Janssen Pharmaceuticals, INC | $174.72 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $159.82 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $129.21 | 2022-2023 | |
| Shockwave Medical, INC | $115.38 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Chiesi USA, INC. | $95.47 | 2019-2022 | |
| Biotronik INC. | $67.54 | 2019 | |
| Cardiva Medical, INC. | $49.56 | 2022 | |
| Teleflex LLC | $35.42 | 2022 | |
| Philips North America LLC | $25.78 | 2019 | |
| Ge Healthcare | $17.15 | 2024 | |
| Heartflow, INC. | $15.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Allencherril listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.